Speakers
Learn from the biggest experts in the world:
Researchers, clinical practitioners, industry professionals
Keynote Speakers
Donald E. Ingber
Wyss Institute
Harvard University
Prof Donald E. Ingber is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and the Hansjörg Wyss Professor of Bioinspired Engineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.
Prof Ingber is a pioneer in the field of biologically inspired engineering, and at the Wyss Institute, he currently leads scientific and engineering teams that cross a broad range of disciplines to develop breakthrough bioinspired technologies to advance healthcare and to improve sustainability. His work has led to major advances in mechanobiology, cell structure, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine. Through his work, Prof Ingber also has helped to break down boundaries between science, art and design.
Najat Khan
Janssen Pharmaceutical Companies
Johnson & Johnson
Dr Najat Khan, PhD, is the Chief Data Science Officer and Global Head of Strategy & Operations for R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson. In this combination of leadership roles—unique in the healthcare industry—Najat is responsible for overseeing the Janssen R&D strategy, pipeline and portfolio optimisation and investment, and for fully integrating data science and digital health end-to-end across the pharmaceutical pipeline to drive transformational innovation for patients.
In 2022, Najat was named on Endpoints News’ list of top 20 leaders under 40 in biopharma and biotech. Prior to joining Janssen, she was a Partner at The Boston Consulting Group (BCG). She received her PhD in Organic Chemistry from the University of Pennsylvania and was a fellow at the Penn Center for Innovation (PCI) focused on translating Penn’s various medical and tech innovations into new products and businesses. Najat completed her BA in Computational Chemistry with a minor in Economics from Colgate University.
Kyunghyun Cho
University of New York
Genentech
Prof Cho is an Associate Professor of computer science and data science at New York University and a Senior Director of frontier research at the Prescient Design team within Genentech Research & Early Development (gRED). He is also a CIFAR Fellow of Learning in Machines & Brains and an Associate Member of the National Academy of Engineering of Korea.
Prof Cho is a pioneer in large language models and natural language processing. Additionally, his research encompasses advancing medicine and protein design using machine learning, among other topics.
Isabelle Guyon
University of Paris-Saclay
Google Brain
Prof Guyon is Director and Research Scientist at Google Brain, as well as Chaired Professor of AI and INRIA Researcher for ML and Optimisation at the Laboratoire Inderdisciplinaire des Sciences du Numérique at the University Paris-Saclay.
Prof Guyon gave a NeurIPS 2022 keynote on datasets and benchmarks: How ML is becoming an experimental science after being co-program chair for the event in 2016 and co-general chair in 2017. She is also president of ChaLearn organising challenges for machine learning.
AMIA and an ELLIS fellow. Action editor at JMLR, and CiML springer series editor. BBVA award recipient (2020).
Megan Gibbs
AstraZeneca
Dr Gibbs Global Head of Clinical Pharmacology & Quantitative Pharmacology
at AstraZeneca.She leads an organisation of R&D scientists that supports all ongoing clinical drug development programmes and global market applications across Oncology, Vaccines and Immune Therapies, Cardiovascular Renal and Metabolic, Respiratory and Immunology.
Her key focus is the use of quantitative methods to impact drug development decision making.
Meet our Speakers
John Humphrey Plummer Professor of Machine Learning, Artificial Intelligence and Medicine at the University of Cambridge and a Fellow at The Alan Turing Institute in London. In addition to leading the van der Schaar Lab, Mihaela is founder and director of the Cambridge Centre for AI in Medicine (CCAIM)
Professor Mihaela van der Schaar
University of CambridgeHead of cellular genetics at the Wellcome Sanger Institute; Director of Research in the Cavendish Laboratory; Visiting Research Group Leader at the European Bioinformatics Institute
Professor Sarah Teichmann
University of Cambridge
Dr William Pritchard
CU HospitalsProfessor of Computational Biology in the Department of Computer Science at the University of Cambridge, Member of the Artificial Intelligence group of the Computer Laboratory.
Prof Pietro Liò
University of Cambridge
Prof Ahmed Alaa
UC Berkeley and UCSFResearch engineer and part-time Ph.D. student at the van der Schaar Lab. Previously AI Resident at Microsoft Research Cambridge.
Evgeny Saveliev
University of CambridgePhD student at the van der Schaar Lab. Holds a MSC in machine learning from UCL, for which he received a Young Talent Award by Prins Bernhard Cultuurfonds and a VSBfonds scholarship.
Boris van Breugel
University of CambridgeProfessor of Respiratory Biology at the University of Cambridge, a Wellcome Trust Senior Investigator, Director of the UK Cystic Fibrosis Innovation Hub, and Co-Director of the Cambridge Centre for AI in Medicine (CCAIM)
Professor Andres Floto
University of CambridgeConsultant in intensive care medicine and deputy chief clinical informatics officer at Cambridge University Hospitals NHS Foundation Trust. Chair of the European Society of Intensive Care Medicine data science scientific section.
Dr Ari Ercole
University of CambridgeResearch Scientist at DeepMind. Received her PhD as part of the van der Schaar lab from the University of Oxford and the Alan Turing Institute.
Dr Ioana Bica
DeepMindSenior Scientist in Machine Learning at the
Department of Hematology,
Copenhagen University Hospital,
Rigshospitalet, Denmark
Dr Rudi Agius
Righospitalet, CopenhagenPhD student at the van der Schaar Lab. She recently completed an MSc in Statistical Science at the University of Oxford, where she graduated with distinction and was awarded the Gutiérrez Toscano Prize.
Alicia Curth
University of CambridgePhD student at the van der Schaar Lab. He joined from the Vrije Universiteit Brussel (VUB). Previously Researcher at the BMW Group in Munich.
Jeroen Berrevoets
University of CambridgeNabeel received a merit scholarship for a master’s degree at Cornell University & holds a master’s degree from the University of the Witwatersrand (South Africa).
Nabeel Seedat
University of CambridgeWellcome Research Fellow at the University of Cambridge, Honorary consultant in nephrology and transplantation, Cambridge University Hospitals NHS Foundation Trust.
Professor Eoin McKinney
University of CambridgeSenior Researcher in the Healthcare Intelligence group
at Microsoft Research.
Dr Stephanie Hyland
Microsoft ResearchPostdoc at the ECE Department, University of California, Los Angeles (UCLA), working with Mihaela van der Schaar in her lab.
Dr Fergus Imrie
University of California (UCLA)/VdS LabSenior Data Scientist and Data Engineer at CCAIM . His educational background is Physical Natural Sciences at the University of Cambridge.
Robert Davis
University of CambridgePhD student in the Department of Applied Mathematics and Theoretical Physics at the University of Cambridge.
Alihan Hüyük
University of CambridgeResearch Fellow & Public Health Physician, UCL and UK National Screening Committee
Dr Thomas Callender
CCAIM/University College LondonDeputy Director of the Kavli Centre for Ethics, Science, and the Public at the University of Cambridge;
Head of Research and Dialogue at Wellcome Connecting Science
Dr Richard Milne
University of CambridgePhD student at the van der Schaar lab. Paulius graduated as Shirley Scholar with an MSc in Social Data Science from Oxford University
. Previously worked as an AI expert for the European Comission and the National Education Agency in Lithuania.
